Finance

Beta
Lists
IRON:NASDAQ
Disc Medicine Inc
$74.20
-3.12%
(-2.39) 1D
Jul 13, 10:24:39 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for IRON...
Open
$76.05
High
$77.98
Low
$72.37
Mkt. cap
2.85B
Avg. vol.
711.37K
Volume
95.85K
52-wk high
$99.50
52-wk low
$40.00
EPS
-$6.61
Beta
0.97
Shares outstanding
38.20M
No. of employees
154
Open
$76.05
High
$77.98
Low
$72.37
Mkt. cap
2.85B
Avg. vol.
711.37K
Volume
95.85K
52-wk high
$99.50
52-wk low
$40.00
EPS
-$6.61
Beta
0.97
Shares outstanding
38.20M
No. of employees
154
News stories
From sources across the web
About Disc Medicine Inc
CEO-
Employees154
Founded2015
HeadquartersWatertown, Massachusetts, United States
SectorBiotechnology
Websitediscmedicine.com
Analyst ratings
Based on 10 analysts giving stock ratings to IRON in the past 3 months
Strong buy
Buy
10
Hold
0
Sell
0
12-month forecast
Based on 10 Wall Street analysts offering 12 month price targets for IRON in the last 3 months.
Highest
Current $74.20
$125.00 (+68.46%)
Average
$101.50 (+36.79%)
Lowest
$85.00 (+14.56%)
Analyst
Recommendation
Action
Price target
Projected
Date
David Nierengarten
Wedbush
Buy
Maintained
$88.00
+18.6%
06/16/2026
Danielle Brill
Truist Financial
Buy
Maintained
-
-
06/16/2026
Sean Laaman
Morgan Stanley
Buy
Reiterated
$85.00
+14.6%
06/16/2026
Rami Katkhuda
LifeSci Capital
Buy
Maintained
$100.00
+34.8%
06/15/2026
Douglas Tsao
H.C. Wainwright
Buy
Reiterated
-
-
06/08/2026
Stephen Willey
Stifel Nicolaus
Buy
Maintained
$111.00
+49.6%
06/03/2026
Evan Seigerman
BMO Capital
Buy
Maintained
$100.00
+34.8%
06/02/2026
Tara Bancroft
TD Cowen
Buy
Initiated
-
-
06/03/2026
Thomas Smith
Leerink Partners
Buy
Reiterated
-
-
06/02/2026
Kristen Kluska
Cantor Fitzgerald
Buy
Maintained
$125.00
+68.5%
05/12/2026
Derek Archila
Wells Fargo
Buy
Maintained
$79.00
+6.5%
03/02/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
46.32M
50.33M
45.37M
45.90M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
15.09M
17.36M
20.75M
23.62M
Operating expense
61.41M
67.70M
66.12M
69.52M
Total operating expenses
61.41M
67.70M
66.12M
69.52M
Operating income
-61.41M
-67.70M
-66.12M
-69.52M
Other non operating income
68.00K
-18.00K
-2.00K
22.00K
EBT including unusual items
-55.20M
-62.22M
-60.44M
-63.45M
EBT excluding unusual items
-55.20M
-62.22M
-59.59M
-63.45M
Income tax expense
52.00K
102.00K
88.00K
51.00K
Effective tax rate
-0.09%
-0.16%
-0.15%
-0.08%
Other operating expenses
-
-
-
-
Net income
-55.25M
-62.32M
-60.53M
-63.50M
Net profit margin
-
-
-
-
Earnings per share
-1.58
-1.77
-1.62
-1.65
Interest and investment income
7.06M
6.41M
7.41M
6.89M
Interest expense
-910.00K
-917.00K
-883.00K
-844.00K
Net interest expenses
6.15M
5.50M
6.53M
6.05M
Depreciation and amortization charges
-
-
-
-
EBITDA
-61.32M
-67.61M
-66.03M
-69.44M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer